Related Experiment Video
Updated: May 4, 2026
06:04
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
722
American college of rheumatology and transcatheter cardiovascular therapeutics
P & T : a Peer-Reviewed Journal for Formulary Management
|January 7, 2014
Insights
Researchers explored rheumatology treatments for rheumatoid arthritis and psoriatic arthritis. They also investigated pharmacological strategies for myocardial infarction and the use of platelet function testing in guiding antiplatelet therapy.
Area of Science:
- Rheumatology
- Cardiology
- Pharmacology
Background:
- Rheumatology encompasses treatments for inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and Behçet's syndrome.
- Cardiology research focuses on acute events such as myocardial infarction and the management of antiplatelet therapy.
Purpose of the Study:
- To review current therapies for specific rheumatological conditions.
- To examine the role of pharmacological interventions in managing myocardial infarction.
- To assess the utility of platelet function testing in guiding antiplatelet treatment.
Main Methods:
- Literature review and synthesis of recent findings in rheumatology.
- Analysis of pharmacological strategies presented at the TCT meeting for myocardial infarction.
- Evaluation of studies on platelet function testing and its impact on antiplatelet therapy.
Main Results:
- Key therapies for rheumatoid arthritis, psoriatic arthritis, and Behçet's syndrome were discussed.
- Pharmacological approaches for myocardial infarction were examined.
- The effectiveness of platelet function testing in personalizing antiplatelet therapy was investigated.
Conclusions:
- Current research offers insights into managing complex rheumatological diseases.
- Understanding pharmacological strategies is crucial for treating myocardial infarction.
- Platelet function testing may optimize antiplatelet therapy, improving patient outcomes.
Abstract:
Rheumatology topics included therapies for rheumatoid arthritis, psoriatic arthritis, and Behçet's syndrome. At the TCT meeting, researchers examined the effects of pharmacological strategies for myocardial infarction, along with platelet function testing as a guide to antiplatelet therapy.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
544
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
544
01:27Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
01:22Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
01:23Rheumatic Heart Disease I: Introduction
1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
689
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
689